Get Thin MD advertises sermorelin injections through plans with different lengths and payment amounts. On the reviewed offer, the one-month option was $189, the three-month option totaled $498, and the six-month option totaled $894. The lower monthly comparison figures come with a larger plan commitment.
We checked the live plan controls, public safety information, and cancellation policy on September 21, 2026. We did not complete intake, checkout, laboratory testing, or a support request. CoreAge Rx receives featured commercial placement here; this review distinguishes Get Thin MD’s published offer from independent evidence about care or outcomes.
Use the selected plan total and renewal terms. Testing badges, an eligibility refund, and other-drug testimonials do not establish sermorelin outcomes.
The active pricing controls give the most useful numbers
Selecting the three plan options showed $189 for one month, $166 per month with a $498 total for three months, and $149 per month with an $894 total for six months. Those figures were attached to the specific injection offer we examined, not a completed patient order.
Other navigation and promotion text displayed different starting-price language. Do not substitute a general site headline for the selected plan. Save the offer and ask what is due immediately, what renews, and whether the rate changes later. Our cost guide helps compare the full commitment rather than choosing whichever number looks lowest.
Confirm the advertised inclusions and how care works
The injection offer lists provider review, medication if appropriate, injection supplies, delivery, provider messaging, and ongoing support. It also says the price is the same at every dose. These are company descriptions of the bundle, not independent verification that a particular prescription or service request has no additional charge.
Ask whether any testing or extra clinical appointment is billed separately and how a new symptom reaches a clinician. Customer-service availability and medical response time are different questions. Confirm whether phone contact is possible if messages are difficult to use, and ask who is responsible for follow-up before another supply is issued.
Identify the preparation and the dispensing pharmacy
The reviewed landing page is for injectable sermorelin, while the wider site also names an oral option. Its footer explains that Get Thin MD connects patients with licensed providers and does not itself manufacture or dispense medication. The service name therefore does not identify the pharmacy on an individual prescription.
Ask for the pharmacy, active ingredients, route, quantity, and preparation-specific directions. Do not transfer a website example regimen to a different vial or an oral product. The provider-types guide explains these separate roles, and the vial-label guide helps you check the eventual supply.
Testing badges are a starting point for questions
The product page describes quality checks and displays testing claims. We did not inspect the batch records behind those claims, identify a report for a patient's vial, or test medication. A passed badge on a marketing page is not the same evidence as a traceable result for a specified material and lot.
Ask what was tested, by whom, and how the testing relates to the finished preparation. Our certificate-of-analysis guide explains why an ingredient purity report, strength assay, and sterility assessment answer different questions. FDA approval also remains separate: compounded medicines are not approved finished products simply because testing is described.
An eligibility refund is not a promise of risk-free treatment
The offer uses risk-free language alongside a refund if a clinician finds the patient ineligible. That is a commercial condition, not a finding that sermorelin cannot cause adverse effects. The separate safety page discusses hormone effects, precautions, and possible reactions.
Ask how medical eligibility is assessed and how a problem during treatment would be handled. Give the clinician a complete medicine and supplement list. The side-effect guide helps frame the discussion. A payment policy should never replace an explanation of expected benefit, uncertainty, and the circumstances that would require clinical reassessment.
Keep the weight-loss evidence with the drug it describes
Get Thin MD's broader footer cites self-reported weight-loss information from people prescribed GLP-1 medication. Its guarantee conditions name compounded semaglutide or tirzepatide. Neither item establishes the effect of sermorelin or a money-back promise for a sermorelin outcome.
A positive testimonial about a clinician may help explain a person's experience, but it still cannot show how this prescription compares with another service's treatment. Read the before-and-after claims guide before using marketing results as a personal forecast. Ask for evidence about the actual medicine, route, and health concern being discussed.
Put the cancellation deadline beside the billing date
The published policy requests cancellation at least 72 hours before the billing date, using the stated contact process. It distinguishes ending future service from receiving a refund and places conditions on refunds and medication already ordered. We did not test how the company handles a particular cancellation or dispute.
Request the exact calendar and governing terms for the selected multi-month plan; general monthly wording does not settle every longer offer. Ask what happens if the prescriber changes treatment partway through. Our subscription and refund guide helps document those questions before a larger payment makes the decision harder to unwind.
Our assessment before choosing a longer plan
Get Thin MD publishes a concrete set of plan totals and a described care bundle. The main issues to resolve are which offer applies, what renews, the actual pharmacy, the scope of testing, and access to clinical follow-up. We have not independently verified delivery speed, support performance, or medication quality.
Use the CoreAge Rx comparison to compare the same period and preparation. The PeterMD review provides a useful contrast because its prices use weeks rather than months. In both cases, a lower effective rate is a purchasing detail; it does not determine how long a clinician should recommend treatment.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- Get Thin MD: Sermorelin injection programProvider primary source · Checked visible offer and plan controls September 21, 2026; promotions and final checkout can differ.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- Get Thin MD: Important safety informationProvider primary source · Multi-product safety page; use the sermorelin section rather than other-drug warnings or claims.
- FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
- FDA: Drug quality sampling and testing programsRegulator guidance · Illustrates distinct quality tests; does not establish testing of any sermorelin product reviewed here.
- Get Thin MD: Fulfillment, cancellation, and refund policyProvider primary source · Published subscription terms; weight-loss guarantee specifically concerns named GLP-1 medications.
- CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
- PeterMD: SermorelinProvider primary source · Visible prices are for four and twelve weeks, not calendar months; page lists Alabama and Idaho exclusions.